The incorporation of artificial intelligence (AI) and digital technology in healthcare has revolutionized service delivery, improving diagnostic precision, patient outcomes, and operational efficacy. Nonetheless, despite considerable progress, numerous problems persist that impede the realization of full potential. Current reviews predominantly emphasize the advantages of AI in disease detection and health guidance, neglecting significant concerns such as social opposition, regulatory frameworks, and geographical discrepancies. This SLR, executed in accordance with PRISMA principles, examined 21 publications from 2020 to 2025 to assess the present condition of AI and digital technologies inside Saudi Arabia’s healthcare industry. Initially, 863 publications were obtained, from which 21 were chosen for comprehensive examination. Significant discoveries encompass the extensive utilization of telemedicine, data analytics, mobile health applications, Internet of Things, electronic health records, blockchain technology, online platforms, cloud computing, and encryption methods. These technologies augment diagnostic precision, boost patient outcomes, optimize administrative procedures, and foster preventative medicine, contributing to cost-effectiveness, environmental sustainability, and enduring service provision. Nonetheless, issues include data privacy concerns, elevated implementation expenses, opposition to change, interoperability challenge, and regulatory issues persist as substantial barriers. Subsequent investigations must concentrate on the development of culturally relevant AI algorithms, the enhancement of Arabic natural language processing, and the establishment of AI-driven mental health systems. By confronting these challenges and utilizing emerging technologies, Saudi Arabia has the potential to establish its status as a leading nation in medical services innovation, guaranteeing patient-centered, efficient, and accessible healthcare delivery. Recommendations must include augmenting data privacy and security, minimizing implementation expenses, surmounting resistance to change, enhancing interoperability, fortifying regulatory frameworks, addressing regional inequities, and investing in nascent technologies.
Fayez Nahedh Alsehani (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: